Is Vascular Endothelial Growth Factor Modulation a Predictor of the Therapeutic Efficacy of Gefitinib for Bladder Cancer?-Reference-Cited by-同舟云学术

Is Vascular Endothelial Growth Factor Modulation a Predictor of the Therapeutic Efficacy of Gefitinib for Bladder Cancer?

Published:2008-09 Issue:3 Volume:180 Page:1146-1153
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kassouf Wassim¹,Brown Gordon A.²,Black Peter C.²,Fisher Mark B.²,Inamoto Teruo²,Luongo Tony²,Gallagher David²,Bar-Eli Menashe³,McConkey David J.³,Adam Liana²,Dinney Colin P.N.⁴

Affiliation:

1. Division of Urology, McGill University Health Center, Montreal, Quebec, Canada

2. Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas

3. Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas

4. University of Texas M. D. Anderson Cancer Center, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer;Crew;Eur Urol,1999

2. Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy;Slaton;J Urol,2004

3. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

4. Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents;Ciardiello;Drugs,2000

5. The Willet F. Whitmore, Jr., Lectureship: blockade of epidermal growth factor receptors as anticancer therapy;Mendelsohn;J Urol,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body mass and smoking are modifiable risk factors for recurrent bladder cancer;Cancer;2013-10-10

2. Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: Dose dependency and modulation of biomarkers;Oncology Reports;2011-05-01

3. Novel targeted agents for the treatment of bladder cancer: translating laboratory advances into clinical application;International braz j urol;2010-06

4. Molecular targets and targeted therapies in bladder cancer management;World Journal of Urology;2008-11-28